Jason Albert Leonard

This inventor holds 12 USPTO granted patents and 1 EPO patent. Top assignees: Pfizer Corporation, Warner Lambert LLC, Warner-Lambert Company. Active years: 2009-2018.

USPTO Granted Patents = 12

% Patents Active = 66.7

EPO Patents = 1

Average Co-Inventor Count = 2.1

ph-index = 4

Forward Citations = 26(Granted Patents)

Location History:

Concord, NH (US) (2011)
Mamaroneck, NY (US) (2009 - 2013)
New Rochelle, NY (US) (2013 - 2018)

Company Filing History:

Warner-Lambert Company

patents

Years Active: 2009-2018

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9908850 - Salt forms of [R—(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-hepatonic acid (2018-03-06),

2. 9637449 - Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic-acid (2017-05-02),

3. 9309195 - Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-hepatanoic acid (2016-04-12),

4. 9073852 - Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid (2015-07-07),

5. 8822703 - Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4[phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid (2014-09-02),

6. 8648109 - Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid magnesium (2014-02-11),

7. 8552207 - Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid (2013-10-08),

8. 8383667 - Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid magnesium (2013-02-26),

9. 8236966 - Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, alpha-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid (2012-08-07),

10. 8084488 - Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid magnesium (2011-12-27),

11. 7875731 - Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)Carbonyl]-1H-pyrrole-1-heptanoic acid (2011-01-25),

12. 7534810 - Salt forms of [R—(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid (2009-05-19),

Title: The Innovative Journey of Inventor Jason Albert Leonard

Introduction

Jason Albert Leonard is a prominent inventor based in New Rochelle, NY, who holds an impressive portfolio of 12 patents. His innovative work primarily focuses on pharmaceutical advancements, specifically in the development of novel compounds for significant health challenges.

Latest Patents

Among his latest patents are innovative salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid. This groundbreaking work includes detailed descriptions of the aforementioned salt forms characterized by their X-ray powder diffraction patterns and solid-state NMR spectra. These compounds are remarkably useful as agents for treating various conditions such as hyperlipidemia, hypercholesterolemia, osteoporosis, benign prostatic hyperplasia, and Alzheimer's Disease.

Career Highlights

Throughout his career, Jason has made significant contributions to the pharmaceutical industry, having worked for notable companies such as Pfizer Corporation and Warner-Lambert Company. His expertise in drug development and formulation has led to advancements that impact the global health landscape.

Collaborations

Jason Albert Leonard has had the privilege of collaborating with esteemed colleagues, including Joseph Francis Krzyzaniak and Jonathan Mark Miller. These professional partnerships have fostered an environment of innovation and collaboration, further enhancing the impact of his work.

Conclusion

With a strong foundation in scientific research and development, Jason Albert Leonard continues to advance the field of pharmaceuticals through his inventive spirit and dedication. His contributions remain vital as the world faces increasing health challenges, making him a noteworthy figure in the realm of innovation and invention.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]